What is Disruptive Pain Therapy?


Neurostimulation is a long-established pain treatment - first developed in 1967.


It is a surgical procedure where small, battery-powered, electrodes are placed near the spinal cord. These electrodes deliver electrical pulses to the affected area, which mask, or interrupt, the transmission of abnormal pain signals to the brain.


In the past Conventional Spinal Cord Stimulation may not have had the best outcomes when treating chronic back pain. It created a tingling or buzzing sensation, known as Paresthesia, and for many patients this was an uncomfortable feeling.


Patients also experienced electrical jolts when they moved about.

Can Spinal Cord Stimulation help me?


Failed back surgery syndrome (FBSS)

Radiculopathy secondary to FBSS or herniated disk

Postlaminectomy pain

Epidural fibrosis

Degenerative disc disease


Complex regional pain syndrome



Through innovative pioneering use of Spinal Cord Stimulation we have we have been able to challenge types of pain that often does not respond to conventional SCS.


Movement disorders



Phantom pain


Occipital Neuralgia

Complex regional pain syndrome

Back Axial Pain -  the most difficult pain to deal with.

What is Neurostimulation?


In 2011 Dr Declan O’Keeffe's Practice became the first clinic in the world to offer patients the latest version of Spinal Cord Stimulation - 10 kHz High-Frequency Therapy (HF10™ therapy). To date we have treated over 300 patients.


The aim of High Frequency Therapy is to interrupt the transmission of abnormal pain signals rather than masking them. To provide pain relief without Paresthesia.


Spinal Cord Stimulation delivers significant improvements in Oswery disability scores, reductions in pain medication and the intake of Opioids. This in turn, results in an improvement in functional capacity and a marked improvement in quality of sleep.


Data from clinical studies show that the success rates of HF10 Therapy are impressive. In a six month, multicenter European study of 83 subjects with significant back pain, 74% reported greater than 50% back pain relief.


In May 2015 the U.S. FDA (Food & Drug Administration) devised a comparative study - funded and delivered by the Nevro Corporation - between conventional and High-Frequency Spinal Cord Stimulation for the treatment of chronic back and leg pain.


As a result the FDA has given Nevro Corp. full approval for Clinical use of its HF10™ therapy, labelling it as a Superior Medical device in comparison to conventional Spinal Cord Stimulation.


We have recently brought the Dorsal Root Ganglion Stimulator - by Axium and the St. Jude Medical Group - to our patients in Ireland and we are currently working with Stimwave Corporation who have developed the world’s smallest, and first wireless, injectable neurostimulator.


Are you Suitable for Spinal Cord Stimulation?